MoonLake Immunotherapeutics
(MLTX - NASDAQ)
15,01 USD
📋 Profilo Aziendale

MoonLake Immunotherapeutics operates as a clinical-stage biopharmaceutical company, concentrating its efforts on discovering and developing novel therapies.

|